BCG Vaccine (Chengdu Keen Biological

卡介苗 ( 成都可恩生物)

Report date: 2025/01/20 11:16:34

Base Information

Drug NameBCG Vaccine (Chengdu Keen Biological

Drug Alias NameN/A

ClassificationVaccines > Application > Therapeutic vaccineVaccines > National Immunization Program > Immunization program vaccine(Class I)Vaccines > Development/production technology > Live attenuated vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsNeoplasm Recurrence, LocalUrinary Bladder NeoplasmsPapilloma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPhase 3 Clinical

Highest Status in ChinaPhase 3 Clinical

Originator CompaniesChengdu Keen Biological Technology Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesChengdu Keen Biological Technology Co Ltd

Inactive CompaniesN/A

Active IndicationsNeoplasm Recurrence, LocalUrinary Bladder NeoplasmsPapilloma

Inactive IndicationsN/A

Other Information

ATC CodeL03AX03